Company intelligence / Profile preview

Astrolabe Diagnostics

Fort Lee, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Astrolabe Diagnostics provides the Astrolabe Cytometry Platform, which enables rapid cloud-based analysis of single-cell cytometry datasets for immune monitoring and research, using machine learning and bioinformatics. It supports basic research, clinical trials, and pharmaceutical collaborations, delivering actionable biological insights in hours rather than weeks or months.

Therapeutic areas: ImmunologyOther
Modalities: Non-pharmacological therapy (cloud-based software/analytics platform for single-cell cytometry data; not a drug or biological therapeutic but an informatics/diagnostics workflow)Software
Industry: Digital Health Medical Devices

Partnerships

Academic medical centers (such as Immune Monitoring Center)pharmaceutical companies for data analytics/profiling collaborations

Beyond the preview

Go deeper on Astrolabe Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astrolabe Diagnostics.

Explore the full profile